abstract - Gynecologic Oncology : The revolving door: Hospital readmissions of gynecologic oncology patients

Conclusions

Hospital readmissions affect the cost of care, but also the quality of care delivered to our patients. When extrapolated across institutions and across the country, unplanned readmissions are a costly expenditure to patients and the health system, deserving of attention.

Research highlights

► Readmissions to the Gynecologic Oncology service affected 13.2% of the population.
► Total cost of readmissions in 5 years at a single academic institution: $6,421,733.
► Unplanned readmissions: 72.6% of the cost for ovarian/uterine/cervical cancer.